Variant · Indel
NPM1 W288FS
CI-VAR-00004690Explore in graph →NP_002511.1:p.Trp288CysfsNM_002520.6:c.860_863dupTCTGClinVar 13998 CIViC 87 rs587776806
Curated evidence
Evidence by cancer (6 items)
Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.
- Source
- CIViC — Clinical Interpretation of Variants in Cancer
- Dataset
- CIViC evidence items
- Version
- civic-2026-09-08
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- expert curation
- License
- CC0 1.0
- PMID
- 27276561
- Run
- ING-CIVIC-20260908-000001
| Molecular profile | Therapy | Type | Level | Direction · significance | Rating (1–5) | Status | Evidence | Source |
|---|---|---|---|---|---|---|---|---|
| Acute Myeloid Leukemia5 | ||||||||
| NPM1 W288FS | (diagnostic) | Diagnostic | A | Supports Positive | 5 | rejected | EID1510In a study of 1,540 patients with Acute Myeloid Leukemia, 418(27%) had mutations in NPM1, mostly W288fs, and there was a preferential co-mutation with NRAS(G12/13), however there was no co-mutation as… (full text at CIViC) PMID 27276561 · Papaemmanuil et al., 2016 · Open in CIViC | civic |
| NPM1 W288FS | (prognostic) | Prognostic | B | Does Not Support Better Outcome | 2 | accepted | EID109No NPM1 mutations were identified in patients with favorable risk cytogenetics (79/215 patients). PMID 21067377 · Ley et al., 2010 · Open in CIViC | civic |
| NPM1 W288FS | (prognostic) | |||||||
ClinVar
Clinical significance (1)
ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.
- Source
- NCBI ClinVar (variant_summary)
- Dataset
- ClinVar variant_summary
- Version
- 2026-09-24
- Retrieved
- Sep 29, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- database
- License
- Public domain (US Government work, NCBI/NLM); acknowledgment requested
- Run
- ING-CLINVAR-20260929-000001
| Variation | Clinical significance | Review status | Stars | Conditions | Origin | Submitters | Last evaluated | Source |
|---|---|---|---|---|---|---|---|---|
| 13998 | Pathogenic | criteria provided, multiple submitters, no conflicts | 2 | Acute myeloid leukemia; Myelodysplastic syndrome progressed to acute myeloid leukemia; NPM1-related disorder | germline/somatic | 5 | Aug 28, 2024 | clinvar |